Dong Lu

Dong Lu

Baylor College of Medicine

H-index: 13

North America-United States

About Dong Lu

Dong Lu, With an exceptional h-index of 13 and a recent h-index of 12 (since 2020), a distinguished researcher at Baylor College of Medicine, specializes in the field of Medicinal chemistry, Chemical Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Lead Compound Development of SRC-3 Inhibitors with Improved Pharmacokinetic Properties and Anticancer Efficacy

Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors

Targeted protein degradation via lysosomes

Applications of covalent chemistry in targeted protein degradation

Discovery of a potent BTK and IKZF1/3 triple degrader through reversible covalent BTK PROTAC development

Development of improved SRC-3 inhibitors as breast cancer therapeutic agents

Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry

Discovery of phthalazinone derivatives as novel hepatitis B virus capsid inhibitors

Dong Lu Information

University

Position

___

Citations(all)

488

Citations(since 2020)

371

Cited By

228

hIndex(all)

13

hIndex(since 2020)

12

i10Index(all)

14

i10Index(since 2020)

13

Email

University Profile Page

Google Scholar

Dong Lu Skills & Research Interests

Medicinal chemistry

Chemical Biology

Top articles of Dong Lu

Lead Compound Development of SRC-3 Inhibitors with Improved Pharmacokinetic Properties and Anticancer Efficacy

Journal of Medicinal Chemistry

2024/3/29

Targeted protein degradation via lysosomes

2022/9/21

Applications of covalent chemistry in targeted protein degradation

2022

Discovery of a potent BTK and IKZF1/3 triple degrader through reversible covalent BTK PROTAC development

Current research in chemical biology

2022/1/1

Development of improved SRC-3 inhibitors as breast cancer therapeutic agents

Endocrine-related cancer

2021/10/1

Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry

Nature communications

2020/8/26

Discovery of phthalazinone derivatives as novel hepatitis B virus capsid inhibitors

Journal of Medicinal Chemistry

2020/7/21

See List of Professors in Dong Lu University(Baylor College of Medicine)